Table:
begin	end	state
1	11	non-cytoplasmic
12	31	transmembrane
32	58	cytoplasmic
59	83	transmembrane
84	88	non-cytoplasmic
89	109	transmembrane
110	137	cytoplasmic
138	158	transmembrane
159	170	non-cytoplasmic
171	193	transmembrane
194	202	cytoplasmic
203	224	transmembrane
225	232	non-cytoplasmic
233	255	transmembrane
256	293	cytoplasmic
294	315	transmembrane
316	338	non-cytoplasmic
339	361	transmembrane
362	377	cytoplasmic
378	403	transmembrane
404	406	non-cytoplasmic
407	427	transmembrane
428	483	cytoplasmic

Input:
>AO353_09955 FitnessBrowser__pseudo3_N2E3:AO353_09955
MLEVINDFLSGKVLIVLIVGLGSYFTIRSRFVQLRHFLHMFSVFKESLRSSSEQLSSFQA
LMLSLAGRVGAGNIAGVGIAVTLGGPGAVFWMWVTALVGMSSSFFECSLGQLYKRCDSEG
QYRGGPSYYIQHGLQKRWLGMIMAFLLLVTFGFAFNGLQSHAVTHSLNNAFGLNTTYTGL
GLAVLLGLVFIGGIKRIAKVADLLVPVKTLVYIGVTIYVIVLQFDHVPGMLMTIVKSAFG
LDQAFGGLIGSAIVMGVKRGVFANEAGLGSAPNVAAVASVEHPVAQGVVQAFSVFLDTFV
ICTCTALLILLSGFYTPGFEGDGIALTQNSLAAVVGDWGRMFISVALALFVFTSILYNYY
LGESNLRFLVGENRKVLIGYRALVLALIFWGAIENLSTVFAFADITMTMLAFVNLIALFL
LFNVGMRILNDYDAQRRAGIKTPVFDSSKFPDLDLDLKAWPANPPAAAPKSEAEPQGVTA
AQR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server